Jeff Huber
General Partner at Triatomic Capital
San Francisco Bay Area
Overview
Work Experience
Co-Founder & General Partner
2022 - Current
‘Applied AI’ in Deep tech, Health tech, & New economy // Helping great entrepreneurs build 'century-defining' businesses & technologies.
Deep tech. Health tech. New economy. AI. Helping great entrepreneurs build 'century-defining' technologies & businesses.
Board of Directors member (public)
2024
Bringing ivonescimab – a novel, first-in-class bi-specific antibody combining immunotherapy via PD-1 blockade and anti-angiogenesis via blocking VEGF in a single molecule – quickly and responsibly to clinical deployment, to help change cancer outcomes for millions of patients.
Board of Directors member
2024
d-Matrix powers next generation compute for generative AI and large language models.
D-Matrix is a computing platform that targets artificial intelligence inferencing workloads in the datacenter.
Raised $154,000,000.00 from Industry Ventures, Nautilus Venture Partners, M12 - Microsoft's Venture Fund, Playground Global, Lam Capital, Temasek Holdings, TGC Square, Cortes capital, Marlan Holding and Ericsson Ventures.
Board of Directors member
2022
Manifold Bio is a next-generation protein therapeutics company pioneering an in-vivo biologics design platform.
Manifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.
Raised $45,399,985.00 from FAST — by GETTYLAB, Tencent, Triatomic Capital, Fifty Years, Section 32, Playground Global, FPV Ventures and Horizons Ventures.
Board of Directors member (public)
2021
Zapata Computing is a quantum computing software & services company – powering quantum-enabled AI, machine learning & optimization for enterprises.
Board of Directors member (public)
2021
Upstart's mission is to enable effortless credit based on true risk, enabled by AI/ML.
Upstart (NASDAQ: UPST) is a leading AI lending marketplace partnering with banks and credit unions to expand access to affordable credit.
Raised $944,050,000.00 from First National Bank Of Omaha, Progressive, Healthcare of Ontario Pension Plan (HOOPP), Rakuten, First Round Capital, Khosla Ventures, Green D Ventures and Third Point Ventures.
Board of Directors member
2020
Mammoth Biosciences is building the CRISPR platform for the next generation of diagnostics, therapeutics, and cell/gene therapies.
Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Raised $264,545,000.00 from Bradley Horowitz, Plum Alley, Decheng Capital, Senator Investment Group, Redmile Group, Sixth Street, Foresite Capital, NFX, Tachyon Ventures and Mayfield Fund.
Board of Directors member
2018
Openwater is creating a new generation of imaging technologies to change how we read and write our bodies and brains.
Chairman / Board of Directors member
2019
Genalyte is a healthcare analytics & diagnostics company improving patient outcomes with real-time point-of-care results.
Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Raised $154,800,000.00 from HBM Partners and Claremont Creek Ventures.
Board of Directors member (public)
2009
Member of Nomination & Governance (2010-2012) and Audit (2012-present) Committees. Helped focus EA’s transition from retail to online/cloud & mobile delivery. Valuation increased 600% over tenure.
Electronic Arts delivers games, content, and online services for internet-connected consoles, PCs, mobile phones, and tablets.
Raised $2,200,000.00 from TCV and TCV.